medline.ch Respirationstrakt Neoplasie

	Thoracic CT Screening in a Population With Unidentified Lung Cancer Risk Factors: Does It Facilitate the Early Diagnosis of Lung Cancer? Can Respir J Gencer A, Ozturk BC, Senkardesler G, Atahan E, Gemicioglu B, Borekci S. PMID: 41199894 [PubMed - indexed for MEDLINE]
	Real-world survival patterns and multimodal therapy utilization in small cell lung cancer: a retrospective cohort study in a Chinese countryside hospital. Front Oncol Huang T, Ma L, Wang M, Pang X, Xu J, Chen X, Xia Y, Yan M, Zhao W, Cheng C, Wang R, Sun K, Wang P. PMID: 41199852 [PubMed]
	Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report. J Dermatol Mochizuki R, Miyazaki R, Nakatani S, Takai T, Sakuma T. PMID: 41199134 [PubMed - indexed for MEDLINE]
	Influence of genetic polymorphisms on gefitinib pharmacokinetics and adverse drug reactions in non-small cell lung cancer patients. Cancer Metastasis Rev Shenoy PV, Baburaj G, Damerla RR, Pai A, Mailankody S, Munisamy M, Mallayasamy S, Udupa KS, Kolesar J, Rao M. PMID: 41199076 [PubMed - indexed for MEDLINE]
	Somatic DICER1 pathogenic variants detected in a well-differentiated fetal lung adenocarcinoma diagnosed in a man with familial adenomatous polyposis. BJC Rep Ahmed A, Thorner PS, Chong AL, Benlimame N, Szlachtycz D, Chong G, Camilleri-Broët S, Foulkes WD. PMID: 41198948 [PubMed]
	Identification of Diagnostic Biomarkers Associated With M1 Macrophage in Lung Squamous Cell Carcinoma via Machine Learning. Front Biosci (Landmark Ed) Deng H, Wang Z, Zhang Q. PMID: 41198554 [PubMed - indexed for MEDLINE]
	Chronic Respiratory Diseases and Lung Cancer Risk. Arch Bronconeumol de-Torres JP, Wilson DO, Wisnivesky JP, Salvatore MM, Polverino E, Seijo LM. PMID: 41198526 [PubMed - as supplied by publisher]
	Artificial intelligence models for lung cancer diagnosis: A comprehensive review. Curr Probl Diagn Radiol Kumar Verma K. PMID: 41198466 [PubMed - as supplied by publisher]
	Association Between Lung Volume Reduction and Symptomatic Radiation Pneumonitis in Lung Cancer Patients Undergoing Definitive Concurrent Chemoradiotherapy. Clin Lung Cancer Lee JW, Lee SW, Kang H, Lee YH. PMID: 41198454 [PubMed - as supplied by publisher]
	Lung Cancer in Older Adults: Screening, Diagnosis, and Treatment. Clin Geriatr Med Chiec L, Roof L, Hsu ML, Presley CJ. PMID: 41198260 [PubMed - indexed for MEDLINE]
	Systematic review and network meta-analysis: evaluation of systemic therapies for platinum refractory or resistant small cell lung cancer. Lung Cancer Desai RK, Zhou EJ, Chan KKW. PMID: 41197381 [PubMed - as supplied by publisher]
	Multiperspective tumor heterogeneity metrics for preoperative prediction of IASLC grading in clinical stage IA lung adenocarcinomas: A multicenter study. Comput Methods Programs Biomed Zuo Z, Fan X, Zeng Y, Qi W, Liu W, Zhang J. PMID: 41197251 [PubMed - as supplied by publisher]
	Pre- and Postoperative Imaging of Lung-sparing Thoracic Resection. Radiographics Tamizuddin F, Kent AJ, Concepcion J, Moore WH, Zervos M, Cerfolio RJ, Ko JP. PMID: 41196717 [PubMed - indexed for MEDLINE]
	Proteome-wide Mendelian randomization and colocalization analysis uncovers druggable targets for lung cancer across multiple phenotypes and complications. Discov Oncol Chen Y, Dai X, Zhang P, Yao L, Wang Q, Qin Z, Gao T, Zhang J. PMID: 41196451 [PubMed]
	Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies. Int J Cancer Yu S, Li H, Lu H, Huang Z, Chen K, Xu Y, Gong L, Xie F, Qin J, Yu X, Zhao J, Lou G, Wang W, Gu C, Han N, Xu X, Shao L, Fan Y. PMID: 41195833 [PubMed - as supplied by publisher]
	Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis. Expert Rev Anticancer Ther Sheida F, Alipour N, Naseri A, Razi S, Manzari Tavakoli G, Moghaddam SJ, Karimi N, Rezaei N. PMID: 41195653 [PubMed - as supplied by publisher]
	Effect of the Combination of Concomitant Drugs on Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Cancer Rep (Hoboken) Saiki M, Takusagawa K, Takahashi N, Homma K, Satoh T, Furuya S, Shimamura S, Omori C, Ohkoshi H, Hoshino Y, Uchida Y, Ikemura S, Soejima K. PMID: 41195639 [PubMed - indexed for MEDLINE]
	Tumor-Associated Macrophages in Lung Cancer: Origins, Functional Heterogeneity, and Therapeutic Implications. J Inflamm Res Tao Y, Xiao J, Li Y, Zou A. PMID: 41195294 [PubMed]
	Radiomics-based decision support tool with ground-glass opacity status of 5-year survival prediction for early-stage non-small cell lung cancer. Rep Pract Oncol Radiother Isobe R, Kawahara D, Imano N, Nishibuchi I, Murakami Y. PMID: 41195102 [PubMed]
	Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitors. Front Immunol Gandara D, Gogishvili M, Sezer A, Makharadze T, Gümü, Zhu C, Yan E, Gullo G, Rietschel P, Quek RGW. PMID: 41194933 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 152232

Seite 1 von 7612



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung